Product Program year 2021 Source: CMS Open Payments

General Stents

Device Pain Management

Open in the dashboard

General payments

$137,523

589 payments

Research payments

$0

0 payments

Through program year 2021, $137,523 in general payments and $0 in research payments were reported against General Stents (Pain Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $137,523 589

Breakdown

Who paid General payments · program year 2021
  1. Boston Scientific Corporation $137,523 589 payments
Top recipients General payments · program year 2021
  1. Emory University Hospital Teaching hospital · GA $50,000 36% · 1 payment
  2. Michael Megaly Cardiovascular Disease · Detroit, MI $25,000 18% · 1 payment
  3. Shawnbir Gogia Interventional Cardiology · Los Angeles, CA $12,500 9% · 1 payment
  4. Thao Duong Cardiovascular Disease · Independence, MO $5,000 4% · 1 payment
  5. Rodrigo Mendirichaga Magana Interventional Cardiology · Dover, NH $5,000 4% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $36,724 49% · 90 practitioners
  2. Interventional Cardiology Internal Medicine $32,112 43% · 197 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $815 1% · 11 practitioners
  4. Internal Medicine $764 1% · 11 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $686 <1% · 20 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Georgia $50,632 37% · 17 recipients
  2. Michigan $29,571 22% · 12 recipients
  3. Massachusetts $13,332 10% · 7 recipients
  4. California $11,490 8% · 27 recipients
  5. New York $8,714 6% · 41 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

589 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record